New Propaq MD Cardiac Monitors/Defibrillators
May 3, 2011
Tulsa, OK -- AeroCare Medical Transport is pleased to announce the acquisition of new cardiac monitors/defibrillators. After reviewing multiple options, AeroCare chose the Propaq MD by ZOLL Medical Corporation.
The Propaq MD is an ultra-lightweight compact device with highly sophisticated, advanced capabilities that combine the well-accepted and proven features of Propaq monitors with the clinically superior therapeutic capabilities of ZOLL defibrillation and non-invasive pacing technologies. The Propaq MD is 60 percent smaller and 40 percent lighter than similar monitor/defibrillators.
The Propaq MD provides an unmatched combination of capabilities that include a large, high-contrast, color LCD display capable of showing up to four waveforms simultaneously, as well as a full 12-lead ECG for on-screen review. All physiological monitoring parameter values, including heart rate, SpO2, ETCO2, respiration, non-invasive blood pressure, two temperatures, and three invasive pressures, are shown in large color-coded numeric formats. The device is capable of monitoring all patients, adult, pediatric or neonatal. The Propaq MD is the only FDA-cleared airworthy defibrillator to provide monitoring of three invasive pressures necessary for treating critical patients during long transports. The system also incorporates a new battery that will monitor all physiological parameters for over six hours on a single battery charge. Designed to withstand the tough demands encompassing air transport, the Propaq MD meets an unprecedented number of international standards related to durability, environmental operation and storage extremes, radio frequency emissions, and susceptibility to spurious electrical and radio frequency noise.
AeroCare continues to be a leader in air medical transportation and quality patient care, now with the new Propaq MD.
